Skip to main content
A

Ananda Pharma Plc — Investor Relations & Filings

Ticker · ANAN ISIN · GB00BDQPXQ60 LEI · 894500DFM8VOC5FW4X47 Aquis Stock Exchange Manufacturing
Open in API
Filings indexed 196 across all filing types
Latest filing 2022-03-31 Regulatory Filings
Country GB United Kingdom
Listing Aquis Stock Exchange ANAN

About Ananda Pharma Plc

https://www.anandapharma.co.uk/

Ananda Pharma Plc is a biopharmaceutical company focused on the development of regulatory-approved, cannabinoid-based medicines. The company's primary mission is to create therapies for complex, chronic inflammatory conditions with significant unmet medical needs. Its development pipeline is initially centered on treatments for inflammatory pain conditions, including Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis, as well as heart failure with preserved ejection fraction (HFpEF). Ananda Pharma's approach covers the full development cycle, from identifying clinical potential and optimizing drug candidates to conducting clinical trials and securing marketing authorizations from regulators.

Recent filings

Filing Released Lang Actions
Ananda Developments Plc - Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a formal announcement regarding 'Total Voting Rights' issued by Ananda Developments Plc. It specifies the total number of ordinary shares and voting rights in accordance with the FCA's Disclosure and Transparency Rules. This type of regulatory disclosure, which provides the denominator for shareholders to calculate their interest, is classified as a general regulatory announcement under the RNS category.
2022-03-31 English
Ananda Developments Plc - Shareholder Update
Regulatory Filings Classification · 95% confidence The document is a 'Shareholder Update' issued by Ananda Developments Plc. It provides operational updates on research programs, commercial growing plans, and corporate developments (specifically regarding a circular for a share purchase). It does not constitute a formal financial report (10-K/IR), a transcript (CT), or a specific regulatory filing like a dividend notice or director dealing. It is a general corporate update released via a Regulatory Information Service (PR Newswire), which falls under the 'Regulatory Filings' (RNS) category as it provides miscellaneous corporate information that does not fit into more specific categories like M&A or Earnings.
2022-03-11 English
Ananda Developments Plc - Exercise of Warrants
Share Issue/Capital Change Classification · 100% confidence The document is an announcement regarding the issuance of new ordinary shares following the exercise of warrants. This falls under the category of capital changes and share issuance. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the correct classification for announcements regarding new share issues.
2022-03-10 English
Ananda Developments Plc - Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a formal announcement regarding 'Total Voting Rights' in accordance with the Financial Conduct Authority's Disclosure and Transparency Rules. It specifies the total number of ordinary shares and voting rights, which is a standard regulatory disclosure requirement for listed companies. Since it does not fit into specific categories like dividend announcements, director dealings, or financial reports, it falls under the general regulatory filing category.
2022-02-28 English
Ananda Developments Plc - Exercise of Warrants
Share Issue/Capital Change Classification · 100% confidence The document announces the issuance of new ordinary shares following the exercise of warrants. This constitutes a change in the company's share capital structure. According to the provided definitions, an announcement regarding new share issues or capital changes falls under the 'Share Issue/Capital Change' (SHA) category.
2022-02-21 English
Ananda Developments Plc - Shareholder Update
Regulatory Filings Classification · 98% confidence The document is a press release issued by Ananda Developments Plc. It provides a business update regarding the commencement of medical cannabis cultivation and details changes to the board of directors (appointment of Stuart Piccaver and Simon Goddard). While it mentions board changes, it is a general corporate update rather than a formal 'Director's Dealing' or 'Board/Management Information' filing. Since it is a general regulatory announcement released via a Regulatory Information Service (PR Newswire) and does not fit into a more specific category like a financial report or dividend notice, it is best classified as a general Regulatory Filing (RNS).
2022-02-04 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.